Clinical Trials Browser

Phase 3 × Leukemia, Myeloid, Acute × tipifarnib × Clear all

Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00093990 2016-09-14

Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Phase 3 Completed

457 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Clinical Trials

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)